THIS EVENT WAS ORGANISED IN PARTNERSHIP WITH:
At Twist Bioscience, we work in service of people who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, our unique silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers.
Visit the website to learn more about how Twist’s DNA Synthesis Platform can enable you.
Samplix offers proprietary products for PCR-free targeted single molecule enrichment of genomic regions. Samplix’ technologies are based on advanced microfluidics which in a simple work process partitions millions of molecules in droplets thereby enabling high quality non-biased targeted enrichment of large fragments (>100 kb) for subsequent sequencing.
Oxford Nanopore Technologies has developed the world’s first nanopore DNA and RNA sequencing devices, which are scalable to your requirements. The MinION is a portable, real-time, long-read, low-cost device designed to bring easy biological analyses to anyone, anywhere, including resource-limited settings or remote environments. The GridION and PromethION devices serve users with larger projects or more samples. Delivering terabases of data, PromethION brings the benefits of long-read nanopore sequencing to large-scale population studies.
With nanopore sequencing devices, fully characterise human genetic variation by sequencing whole genomes, targeted regions or full-length RNA transcripts, from single cells to tissues. Long nanopore reads allow comprehensive analysis of structural variation, repetitive regions, haplotype phasing, RNA splice variants, isoforms, fusion transcripts and base modifications. Long sequencing reads enable resolution of challenging genomic regions and the delivery of more complete human genome assemblies. Experience streamlined, rapid end-to-end solutions with library preparation in as little as 10 minutes, and faster access to results with real-time analysis.
Oxford Nanopore Technologies products are currently for Research Use Only.
Nonacus is a precision medicine company and developer of innovative genomic healthcare solutions.
Based in Birmingham UK, the company develops novel NGS library preparation solutions primarily in the non-invasive healthcare space and based on next-generation sequencing, targeted DNA sequencing and real-time qPCR kits.
Nonacus products are designed to help customers analyse the most difficult of samples with a particular focus on cfDNA and FFPE. Allowing samples to be processed faster and with greater sensitivity and accuracy, while being compatible with leading instrumentation.
CeGat is one of the world-wide leaders in clinical genetics. It is a Germany-based company with subsidiaries in China and the USA. CeGaT was established in 2009 and was the first medical genetic company in Europe to introduce diagnostic panel approach. CeGaT’s highest diagnostic quality is confirmed by CAP, CLIA and ISO15189 certificates/accreditations.
The company offers a vast range of tests and methods such as single-gene sequencing/MLPA analysis, NGS panel (disease-related) sequencing, whole exome sequencing (WES Trio or single), array CGH and segregation analysis. In addition, Research and Pharma Solutions Dept. Of CeGaT offers a big range of customized NGS services (e.g. WGS, RNA profiling, metabiome sequencing etc.) for human, animal, plant or microbial samples.
Congenica is a digital health company enabling genomic medicine with the world’s leading clinical decision support platform for accelerated genomic data interpretation.
We are committed to integrating clinical genomics into healthcare. Built on a foundation of clinical genomics expertise, we develop software products and services that make the use of complex genomic data routine, accessible and ubiquitous.Our headquarters are on the Wellcome Genome Campus in Cambridge, UK, however our reach is global. We are driven to empower Healthcare Professionals everywhere to transform health and wellness by converting genomic data into actionable information to provide life-changing answers.
Bionano is a life science company who developed the Saphyr system for the genome wide, unbiased detection of structural variants (SVs) starting from 500bp. While next generation sequencing induces lot of errors with SV detection due reads length and the repetitive nature of the genome, our mapping technology bypasses that by directly imaging single, large DNA molecules (250kb on average) allowing us to reconstitute maps the length of an entire chromosome arm.
We recently released new tools bringing coverage to 300X for the human genome (1.3Tbp), providing unrivalled depth for the detection of rare allelic variants, a common pitfall in the study of heterogenous cancer samples. Finally, users contributed over the years to diversify our applications with genome wide methylation study (as seen in a recent publication), genome editing safety studies or detection of insertion of exogenous sequence.
Our non-sequencing-based genome mapping technology images and analyses extremely long, high-molecular-weight DNA to provide views of genomes that no other technology can provide.